MKI67 and hepatocellular carcinoma: Taken together, this study suggests that the MRI-based radiomics plus clinical risk factor model can be used for predicting Ki-67 and CK-19 expression in HCC using 10% LI and 5% LI as the positive thresholds for the two markers, respectively.